Mon, January 10, 2011
[ Mon, Jan 10th 2011 ]: Market Wire
ACADIA Pharmaceuticals Announces $15 Million Private Placement
[ Mon, Jan 10th 2011 ]: Market Wire
NPS Pharmaceuticals Announces Completion of Treat .. istration Study of GATTEX in Short Bowel Syndrome
[ Mon, Jan 10th 2011 ]: Market Wire
OPKO Health to Collaborate with Bristol-Myers Squibb on Blood Test for Alzheimera?s Disease
[ Mon, Jan 10th 2011 ]: Market Wire
Unigene Provides 2011 Business Outlook
[ Mon, Jan 10th 2011 ]: Market Wire
BioSante Pharmaceuticals Confirms Female Sexual Dysfunction as an Unmet Medical Need
[ Mon, Jan 10th 2011 ]: Market Wire
Enzon to Begin Phase 1 Study of Novel Androgen Re .. ntagonist in Castration-Resistant Prostate Cancer
[ Mon, Jan 10th 2011 ]: Market Wire
Pro-Pharmaceuticals Receives Positive FDA Feedbac .. cal Trial Design to Treat Patients With Colorecta
[ Mon, Jan 10th 2011 ]: Market Wire
Medisafe 1 Technologies Receives Endorsement for .. tion From Israel's Pharmaceuticals Administration
[ Mon, Jan 10th 2011 ]: Market Wire
Oncolytics Biotech® Inc. Announces Opening o .. nrollment in U.S. Phase I Colorectal Cancer Study
[ Mon, Jan 10th 2011 ]: Market Wire
American Medical Systems Announces Fourth Quarter 2010 Revenue Performance
[ Mon, Jan 10th 2011 ]: Market Wire
Emergent BioSolutions Provides Preliminary 2010 Financial Results and Guidance for 2011
[ Mon, Jan 10th 2011 ]: Market Wire
U.S. PENNSAID SALES CONTINUE TO GROW
[ Mon, Jan 10th 2011 ]: Market Wire
Human Genome Sciences Reports Progress Toward Sus .. nces 2011 Goals at JPMorgan Healthcare Conference
[ Mon, Jan 10th 2011 ]: Market Wire
Exelixisa? XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
[ Mon, Jan 10th 2011 ]: Market Wire
Illumina Introduces the Next Generation of iSelect® Custom Genotyping
Sun, January 9, 2011
[ Sun, Jan 09th 2011 ]: Market Wire
Inhibitex Reports Positive Interim Safety and Ant .. hase 1b Study of HCV Nucleotide Inhibitor INX-189
[ Sun, Jan 09th 2011 ]: Market Wire
AMAG Pharmaceuticals Provides Business Update
[ Sun, Jan 09th 2011 ]: Market Wire
LecTec Corporation Announces Trial Adjourned Until April 11, 2011
[ Sun, Jan 09th 2011 ]: Market Wire
Vertex Announces Key Business Objectives To Suppo .. ir in Hepatitis C and Continued Progress in Other
Fri, January 7, 2011
[ Fri, Jan 07th 2011 ]: Market Wire
Tenet Adopts Stockholder Rights Plan to Protect Net Operating Loss Carryforward Assets
[ Fri, Jan 07th 2011 ]: Market Wire
Quidel to Present at JP Morgan 29th Annual Healthcare Conference
[ Fri, Jan 07th 2011 ]: Market Wire
Medtronic CEO William Hawkins to Speak at J.P. Morgan Healthcare Conference
[ Fri, Jan 07th 2011 ]: Market Wire
Synergy Pharmaceuticals anuncia nuevo plan de desarrollo clnico para plecanatide
[ Fri, Jan 07th 2011 ]: Market Wire
Teva to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Fri, Jan 07th 2011 ]: Market Wire
Humana Inc. to Release Fourth Quarter 2010 Results on February 7, 2011
[ Fri, Jan 07th 2011 ]: Market Wire
Synergy Pharmaceuticals gibt neuen Plan fr die klinische Entwicklung von Plecanatide bekannt
[ Fri, Jan 07th 2011 ]: Market Wire
Synergy Pharmaceuticals annuncia un nuovo piano di sviluppo clinico per il Plecanatide
[ Fri, Jan 07th 2011 ]: Market Wire
Synergy Pharmaceuticals annonce un nouveau plan de d©veloppement clinique pour le plecanatide
[ Fri, Jan 07th 2011 ]: Market Wire
Geron to Present at J.P. Morgan Annual Healthcare Conference
[ Fri, Jan 07th 2011 ]: Market Wire
Biogen Idec nombra a Doug Williams Vicepresidente .. tzman Vicepresidente ejecutivo de desarrollo corp
[ Fri, Jan 07th 2011 ]: Market Wire
ShangPharma Announces Appointment of New Chief Fi .. Officer and Promotion of Kevin Chen as President
[ Fri, Jan 07th 2011 ]: Market Wire
Opexa???????FDA???,???Tovaxin®????????3?????
[ Fri, Jan 07th 2011 ]: Market Wire
AngioDynamics to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Fri, Jan 07th 2011 ]: Market Wire
Orthofix International to Participate in JP Morgan 29th Annual Healthcare Conference
Thu, January 6, 2011
[ Thu, Jan 06th 2011 ]: Market Wire
Cambridge Heart to Present at OneMedForum San Francisco 2011
[ Thu, Jan 06th 2011 ]: Market Wire
Humana Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Thu, Jan 06th 2011 ]: Market Wire
Covidien meldet die Verfgbarkeit der Nellcora" Ox .. standteil des Infinity® Acute Care Systems von D
[ Thu, Jan 06th 2011 ]: Market Wire
Biogen Idec ernennt Doug Williams zum Leiter der .. bteilung und Steven Holtzman zum Leiter der Unter
[ Thu, Jan 06th 2011 ]: Market Wire
Covidien annuncia la disponibilit della tecnologi .. l'Infinity® Acute Care System di Drger in Europa
[ Thu, Jan 06th 2011 ]: Market Wire
Covidien kondigt beschikbaarheid aan van Nellcora .. met Drger Infinity® Acute Care System in Europa
[ Thu, Jan 06th 2011 ]: Market Wire
Biogen Idec nomina Doug Williams responsabile del .. Steven Holtzman a capo del Corporate Development
[ Thu, Jan 06th 2011 ]: Market Wire
Celgene annonce le d©p't de soumissions r©glementaires
[ Thu, Jan 06th 2011 ]: Market Wire
Covidien Announces the Availability of Nellcora" .. with Drger Infinity® Acute Care System in Europe
[ Thu, Jan 06th 2011 ]: Market Wire
XIFAXAN® 550 mg Tablets Demonstrated Significant .. Irritable Bowel Syndrome Without Constipation Ac
[ Thu, Jan 06th 2011 ]: Market Wire
SurModics and Ramius Reach Agreement Regarding 2011 Annual Meeting of Shareholders
[ Thu, Jan 06th 2011 ]: Market Wire
Vertex Pharmaceuticals Announces Webcast of its P .. the 29th Annual J.P. Morgan Healthcare Conference
[ Thu, Jan 06th 2011 ]: Market Wire
Chemed Corporation to Present at the29th Annual J.P. Morgan Healthcare Conference
[ Thu, Jan 06th 2011 ]: Market Wire
Celgene verffentlicht aktuelle Informationen ber Zulassungsverfahren

Biogen Idec nombra a Doug Williams Vicepresidente ejecutivo I+D y a Steven Holtzman Vicepresidente ejecutivo de desarrollo corp

  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. vicepresidente-ejecutivo-de-desarrollo-corp.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

WESTON, Massachussets--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) ha comunicado que Douglas E. Williams, Ph.D., ha sido nombrado Vicepresidente ejecutivo de investigacin y desarrollo (I+D), y Steven H. Holtzman ha sido nombrado Vicepresidente ejecutivo de desarrollo corporativo. El Dr. Williams supervisar las operaciones globales de I+D de la empresa, incluidas las operaciones clnicas, de desarrollo e investigacin de descubrimientos as como asuntos normativos.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.